平滑肌肉瘤：100例患者的临床病理研究及预后因素回顾性分析
Leiomyosarcoma: Clinicopathological study and retrospective analysis of prognostic factors in a series of 100 patients.
作者信息
Muratori Francesco, Greto Daniela, Cenatiempo Mauro, Mazzei Giacomo, Frenos Filippo, Roselli Giuliana, Livi Lorenzo, Capanna Rodolfo, Baldi Giacomo, Campanacci Domenico Andrea
机构信息
Divisione di Ortopedia Oncologica e Ricostruttiva Azienda Ospedaliero Universitaria Careggi Firenze, Italy.
Unità di Radioterapia Azienda Ospedaliero Universitaria Careggi Firenze, Italy.
出版信息
J Orthop. 2019 Mar 25;16(4):303-307. doi: 10.1016/j.jor.2019.03.004. eCollection 2019 Jul-Aug.
The Authors reported a retrospective study of 100 Leiomyosarcoma (LMS), evaluating factors that may influence Overall Survival (OS), Local Recurrence Free Survival (LRFS), Metastasis Free Survival (MFS). Tumor Size (P = 0,0009), Local Recurrence (P = 0,0487), Distant relapse (P < 0,0001), Type of Presentation (P = 0,0213) were significant risk factors affecting overall survival (OS). Tumor Size (P = 0.024), age at diagnosis (P = 0,0086), type of presentation (P < 0,0001) and Local Recurrence (P = 0.0152) affected metastasis free survival (MFS). Type of presentation (P = 0,001) was an independent prognostic factor of local recurrence-free survival (LRFS).
作者报告了一项对100例平滑肌肉瘤（LMS）的回顾性研究，评估了可能影响总生存期（OS）、无局部复发生存期（LRFS）、无转移生存期（MFS）的因素。肿瘤大小（P = 0.0009）、局部复发（P = 0.0487）、远处复发（P < 0.0001）、临床表现类型（P = 0.0213）是影响总生存期（OS）的显著危险因素。肿瘤大小（P = 0.024）、诊断时年龄（P = 0.0086）、临床表现类型（P < 0.0001）和局部复发（P = 0.0152）影响无转移生存期（MFS）。临床表现类型（P = 0.001）是无局部复发生存期（LRFS）的独立预后因素。
Zotero 插件